{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:28:28Z","timestamp":1790270908828,"version":"4.1.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188045","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T18:33:44Z","timestamp":1511202824000},"page":"e0188045","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS"],"prefix":"10.1371","volume":"12","author":[{"given":"Sophie","family":"Doublier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Zennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Musante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Spatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Candiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Bruschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Besso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cedrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Camussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-1217","authenticated-orcid":true,"given":"Enrico","family":"Lupia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.22.012703.104533","article-title":"CD40\/CD154 interactions at the interface of tolerance and immunity","volume":"22","author":"SA Quezada","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacc.2009.03.076","article-title":"The CD40\/CD40 ligand system: linking inflammation with atherothrombosis","volume":"54","author":"C Antoniades","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.imbio.2011.03.010","article-title":"CD40 ligand: a neo-inflammatory molecule in vascular diseases","volume":"217","author":"GS Hassan","year":"2012","journal-title":"Immunobiology"},{"issue":"1\u20132","key":"ref4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.imlet.2013.07.005","article-title":"The CD40\/CD40L system: a new therapeutic target for disease","volume":"153","author":"B Zhang","year":"2013","journal-title":"Immunol Lett"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/08830185.2013.829470","article-title":"Costimulatory pathways in kidney transplantation: pathogenetic role, clinical significance and new therapeutic opportunities","volume":"33","author":"P Esposito","year":"2014","journal-title":"Int Rev Immunol"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1097\/01.ASN.0000091381.60059.FB","article-title":"Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis","volume":"14","author":"AJ Ruth","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1523-1755.2004.00907.x","article-title":"Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis","volume":"66","author":"J Reynolds","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ndt\/gfp569","article-title":"The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis","volume":"25","author":"VW Lee","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1523-1755.2003.00223.x","article-title":"Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease","volume":"64","author":"L Kairaitis","year":"2003","journal-title":"Kidney Int"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1097\/01.ASN.0000029588.07166.20","article-title":"Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40\/CD40 ligand pathway and may amplify glomerular injury","volume":"13","author":"T Tanaka","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1681\/ASN.2005010045","article-title":"CD40: a mediator of pro- and anti-inflammatory signals in renal tubular epithelial cells","volume":"16","author":"S Laxmanan","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1681\/ASN.2002120972","article-title":"CD40 ligand increases complement C3 secretion by proximal tubular epithelial cells","volume":"16","author":"G Castellano","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/039463200501800215","article-title":"CD40-dependent activation of phosphatidylinositol 3-kinase\/AKT pathway inhibits apoptosis of human cultured mesangial cells induced by oxidized LDL","volume":"18","author":"I Deambrosis","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"256","key":"ref14","doi-asserted-by":"crossref","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"M Delville","year":"2014","journal-title":"Sci Transl Med"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/jcb.25571","article-title":"CD154 Induces Matrix Metalloproteinase-9 Secretion in Human Podocytes","volume":"117","author":"C Rigothier","year":"2016","journal-title":"J Cell Biochem"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/gt.2011.39","article-title":"In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection","volume":"18","author":"E Ripoll","year":"2011","journal-title":"Gene therapy"},{"key":"ref17","article-title":"IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy","author":"HL Kuo","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"14","key":"ref18","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199604043341402","article-title":"Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis","volume":"334","author":"VJ Savin","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1681\/ASN.V121143","article-title":"Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis","volume":"12","author":"G Candiano","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/snep.2003.50024","article-title":"Permeability factors in focal segmental glomerulosclerosis","volume":"23","author":"VJ Savin","year":"2003","journal-title":"Semin Nephrol"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.ASN.0000051640.04273.75","article-title":"Circulating permeability factors in the nephrotic syndrome: a fresh look at an old problem","volume":"14","author":"RJ Glassock","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2013.204","article-title":"Has the circulating permeability factor in primary FSGS been found?","volume":"84","author":"JA Jefferson","year":"2013","journal-title":"Kidney Int"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ckj\/sfv090","article-title":"A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues","volume":"8","author":"T Wada","year":"2015","journal-title":"Clin Kidney J"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","article-title":"The glomerular permeability factors in idiopathic nephrotic syndrome","volume":"31","author":"JC Davin","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/ndt\/gfu355","article-title":"Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future","volume":"29","author":"RJ Maas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1600-6143.2005.00968.x","article-title":"New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis","volume":"5","author":"F Vincenti","year":"2005","journal-title":"Am J Transplant"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","article-title":"Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis","volume":"5","author":"ET McCarthy","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1053\/j.ackd.2014.05.010","article-title":"Permeability factors in focal and segmental glomerulosclerosis","volume":"21","author":"J Reiser","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6232616","DOI":"10.1155\/2017\/6232616","article-title":"Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor","volume":"2017","author":"VJ Savin","year":"2017","journal-title":"Biomed Res Int"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1128\/JVI.71.12.9180-9187.1997","article-title":"Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells","volume":"71","author":"PG Conaldi","year":"1997","journal-title":"J Virol"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1172\/JCI3480","article-title":"HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation","volume":"102","author":"PG Conaldi","year":"1998","journal-title":"J Clin Invest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.2147\/IJN.S110201","article-title":"A nanoporous surface is essential for glomerular podocyte differentiation in three-dimensional culture","volume":"11","author":"C Zennaro","year":"2016","journal-title":"International journal of nanomedicine"},{"issue":"1","key":"ref33","first-page":"49","article-title":"Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes","volume":"16","author":"S Doublier","year":"2005","journal-title":"Int J Mol Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"MM Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0002-9440(10)64128-4","article-title":"Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome","volume":"158","author":"S Doublier","year":"2001","journal-title":"Am J Pathol"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.0000070111.98158.6C","article-title":"CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation","volume":"92","author":"DP Inwald","year":"2003","journal-title":"Circ Res"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfh144","article-title":"CD40 is expressed on rat peritoneal mesothelial cells and upregulates ICAM-1 production","volume":"19","author":"X Yang","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00125-004-1645-7","article-title":"A functional CD40 receptor is expressed in pancreatic beta cells","volume":"48","author":"D Klein","year":"2005","journal-title":"Diabetologia"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2337\/diabetes.52.4.1023","article-title":"Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II","volume":"52","author":"S Doublier","year":"2003","journal-title":"Diabetes"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1681\/ASN.V361260","article-title":"Measurement of albumin reflection coefficient with isolated rat glomeruli","volume":"3","author":"VJ Savin","year":"1992","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM199401063300102","article-title":"Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome","volume":"330","author":"J Dantal","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1681\/ASN.V103552","article-title":""The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma","volume":"10","author":"M Sharma","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000183664","article-title":"The vascular permeability factor is a T lymphocyte product","volume":"42","author":"JM Heslan","year":"1986","journal-title":"Nephron"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.bbadis.2017.06.010","article-title":"Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors","volume":"1863","author":"EY Kim","year":"2017","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00441-011-1169-7","article-title":"Mechanisms and consequences of TGF-ss overexpression by podocytes in progressive podocyte disease","volume":"347","author":"HS Lee","year":"2012","journal-title":"Cell Tissue Res"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1681\/ASN.2007080940","article-title":"Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes","volume":"19","author":"R Lennon","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"C Wei","year":"2011","journal-title":"Nat Med"},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1681\/ASN.2013040425","article-title":"Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice","volume":"25","author":"D Cathelin","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"ref49","first-page":"103","article-title":"Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor","volume":"2","author":"H Trimarchi","journal-title":"World J Nephrol"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nm.2443","article-title":"A suPAR circulating factor causes kidney disease","volume":"17","author":"SJ Shankland","year":"2011","journal-title":"Nat Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"714964","DOI":"10.1155\/2015\/714964","article-title":"Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family","volume":"2015","author":"VJ Savin","year":"2015","journal-title":"J Immunol Res"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"F138","DOI":"10.1152\/ajprenal.00122.2008","article-title":"Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (P(alb))","volume":"297","author":"DS Charba","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2249.2005.02862.x","article-title":"Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome","volume":"141","author":"L Musante","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMc1207233","article-title":"Angiotensin antibodies and focal segmental glomerulosclerosis","volume":"368","author":"N Alachkar","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"ref55","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1681\/ASN.V991709","article-title":"Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome","volume":"9","author":"J Dantal","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3182977ab1","article-title":"Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates","volume":"96","author":"CR Franco Palacios","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1038\/s41598-017-08426-8","article-title":"Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease","volume":"7","author":"JX Xie","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2008.09.006","article-title":"CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease","volume":"14","author":"M Rizvi","year":"2008","journal-title":"Trends Mol Med"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1160\/TH09-01-0029","article-title":"The multi-functionality of CD40L and its receptor CD40 in atherosclerosis","volume":"102","author":"D Lievens","year":"2009","journal-title":"Thromb Haemost"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/07853890.2010.546362","article-title":"The CD40-CD40L system in cardiovascular disease","volume":"43","author":"B Pamukcu","year":"2011","journal-title":"Ann Med"},{"issue":"10","key":"ref61","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1007\/s13277-014-2407-x","article-title":"Multifunctional CD40L: pro- and anti-neoplastic activity","volume":"35","author":"A Korniluk","year":"2014","journal-title":"Tumour Biol"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ctrv.2015.03.007","article-title":"Role of CD154 in cancer pathogenesis and immunotherapy","volume":"41","author":"GS Hassan","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/08830185.2012.698338","article-title":"The use of agonistic anti-CD40 therapy in treatments for cancer","volume":"31","author":"A Khong","year":"2012","journal-title":"Int Rev Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T18:37:24Z","timestamp":1659897444000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188045"}},"subtitle":[],"editor":[{"given":"Stuart E.","family":"Dryer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188045","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]}}}